Feature Gynaecology Experimental treatments risk further medicalisation of menopause BMJ 2021; 373 doi: https://doi.org/10.1136/bmj.n992 (Published 11 May 2021) Cite this as: BMJ 2021;373:n992 Article Related content Metrics Responses Peer review Related articles Practice Non-hormonal treatments for menopausal symptoms Published: 23 November 2017; BMJ 359 doi:10.1136/bmj.j5101 See more University of California to pay out nearly $700m over gynaecologist accused of sexual abuse BMJ May 26, 2022, 377 o1335; DOI: https://doi.org/10.1136/bmj.o1335 Oklahoma governor signs strictest ban on abortion in the US BMJ May 26, 2022, 377 o1334; DOI: https://doi.org/10.1136/bmj.o1334 Pfizer pledges to provide 23 drugs at not-for-profit prices to lower income countries BMJ May 26, 2022, 377 o1329; DOI: https://doi.org/10.1136/bmj.o1329 Tom Nolan’s research reviews—26 May 2022 BMJ May 26, 2022, 377 o1290; DOI: https://doi.org/10.1136/bmj.o1290 GP is jailed for 12 years for sexually abusing 47 female patients BMJ May 26, 2022, 377 o1328; DOI: https://doi.org/10.1136/bmj.o1328
